Pharmaceuticals and personal care products (PPCPs) in Australia's largest inland sewage treatment plant, and its contribution to a major Australian river during high and low flow

Science of the Total Environment

Volumn 541, Issue , 2016, Pages 1625-1637

  Roberts, Jenna ^a,b   Kumar, Anupama ^a   Du, Jun ^a   Hepplewhite, Christopher ^d   Ellis, David J ^b   Christy, Andrew G ^b   Beavis, Sara G ^c  

^a CSIRO   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^d NONE   (Australia)

Author keywords

Australia; Freshwater; Personal care products; Pharmaceuticals; Seasonal; Sewage

Indexed keywords

CATCHMENTS; DILUTION; DRUG PRODUCTS; EFFICIENCY; EFFLUENT TREATMENT; REMOVAL; RISK ASSESSMENT; RIVERS; RUNOFF; SEWAGE; SEWAGE TREATMENT PLANTS;

AUSTRALIA; EFFLUENT CONCENTRATIONS; FRESHWATER; PERSONAL CARE PRODUCTS; PHARMACEUTICALS AND PERSONAL CARE PRODUCTS; PREDICTIVE CAPABILITIES; RISK ASSESSMENT MODELS; SEASONAL;

EFFLUENTS;

DRUG; EFFLUENT; FRESHWATER; POLLUTANT REMOVAL; PPCP; RISK ASSESSMENT; RIVER FLOW; SEASONALITY; SEWAGE TREATMENT;

AUSTRALIA; MOLONGLO RIVER; MURRUMBIDGEE RIVER; NEW SOUTH WALES;

COSMETIC; DRUG; WATER POLLUTANT;

ANALYSIS; AUSTRALIA; CHEMISTRY; ENVIRONMENTAL MONITORING; RIVER; SEWAGE; WATER POLLUTANT;

AUSTRALIA; COSMETICS; ENVIRONMENTAL MONITORING; PHARMACEUTICAL PREPARATIONS; RIVERS; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL;

EID: 84952979926     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2015.03.145     Document Type: Article

References (90)

1. Actew Water Sewage Treatment Process (ACTEW Corporation 2011 Accessed July 2014). http://www.actew.com.au/Water%20and%20Sewerage%20Systems/ACT%20Sewerage%20System/What%20is%20sewage/Sewage%20Treatment%20Process.aspx.
2. Agüera A., Fernández-Alba A.R., Piedra L., Mézcua M., José Gómez M. Evaluation of triclosan and biphenylol in marine sediments and urban wastewaters by pressurized liquid extraction and solid phase extraction followed by gas chromatography mass spectrometry and liquid chromatography mass spectrometry. Anal. Chim. Acta 2003, 480:193-205.
3. AIHW Australian Institute of Health and Welfare. Allergic Rhinitis ('Hay Fever') in Australia 2011, AIHW, Canberra, (Cat. no. ACM 23).
4. Alder A., Schaffner C., Majewski M., Klasmeier J., Fenner K. Fate of β-blocker human pharmaceuticals in surface water: Comparison of measured and simulated concentrations in the Glatt Valley Watershed, Switzerland. Water Res. 2010, 44:936-948.
5. ASCIA Pollen Allergy 2010, Australasian Society of Clinical Immunology and Allergy, (www.allergy.org.au Accessed July 2014).
6. Baronti C., Curini R., D'Ascenzo G., Di Corcia A., Gentili A., Samperi R. Monitoring natural and synthetic estrogens at activated sludge sewage treatment plants and in a receiving river water. Environ. Sci. Technol. 2000, 34(24):5059-5066.
7. Bartelt-Hunt S.L., Snow D.D., Damon T., Shockley J., Hoagland K. The occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and surface waters in Nebraska. Environ. Pollut. 2009, 157:786-791.
8. Behera S.K., Kim H.W., Oh J.E., Park H.S. Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea. Sci. Total Environ. 2011, 409:4351-4360.
9. Berninger J.P., Du B., Connors K.A., Eytcheson S.A., Kolkmeier M.A., Prosser K.N., Valenti T.W., Chambliss C.K., Brooks B.W. Effects of the antihistamine diphenhydramine on selected aquatic organisms. Environ. Toxicol. Chem. 2011, 30(9):2065-2072.
10. Bisesi J.H., Bridges W., Klaine S.J. Effects of the antidepressant venlafaxine on fish brain serotonin and predation behaviour. Aquat. Toxicol. 2014, 148130-148138.
11. Brooks B.W., Riley T.M., Taylor R.D. Water quality of effluent-dominated ecosystems: ecotoxicological, hydrological and management considerations. Hydrobiologia 2006, 556(1):365-379.
12. Castiglioni S., Bagnati R., Fanelli R., Pomati F., Calamari D., Zuccato E. Removal of pharmaceuticals in sewage treatment plants in Italy. Environ. Sci. Technol. 2006, 40:357-363.
13. Clara M., Strenn B., Gans O., Martinez E., Kreuzinger N., Kroiss H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res. 2005, 39:4797-4807.
14. Commissioner for Sustainability and the Environment Report on the State of the Water Courses and Catchments for Lake Burley Griffin 2012, ACT Government, Canberra.
15. Conley J.M., Symes S.J., Schorr M.S., Richards S.M. Spatial and temporal analysis of pharmaceutical concentrations in the upper Tennessee River basin. Chemosphere 2008, 73:1178-1187.
16. Conners D.E., Rogers E.D., Armbrust K.L., Kwon J.W., Black M.C. Growth and development of tadpoles (Xenopus laevis) exposed to selective serotonin reuptake inhibitors, fluoxetine and sertraline, throughout metamorphosis. Environ. Toxicol. Chem. 2009, 28(12):2671-2676.
17. Crofton K.M., Paul K.B., DeVito M.J., Hedge J.M. Short-term in vivo exposure to the water contaminant triclosan: evidence for disruption of thyroxine. Environ. Toxicol. Pharmacol. 2007, 24:194-197.
18. Dai G., Huang J., Chen W., Wang B., Yu G., Deng S. Major pharmaceuticals and personal care products (PPCPs) in wastewater treatment plant and receiving water in Beijing, China, and associated ecological risks. Bull. Environ. Contam. Toxicol. 2014, 92:655-661.
19. Pharmaceuticals and personal care products in the environment: scientific and regulatory issues. American Chemical Society Symposium Series 2001, 791. ACS/Oxford University Press, Washington D.C. C.G. Daughton, T.L. Jones-Lepp (Eds.).
20. DHA Australian Government Department of Health and Ageing. Australian Statistics on Medicines 2010, ( Commonwealth of Australia 2012).
21. Drury B., Scott J., Rosi-Marshall E.J., Kelly J.J. Triclosan exposure increases triclosan resistance and influences taxonomic composition of benthic bacterial communities. Environ. Sci. Technol. 2013, 47:8923-8930.
22. Du B., Haddad S.P., Luek A., Scott C., Saari G.N., Kristofco L.A., Connors K.A., Rash C., Rasmussen J.B., Chambliss K., Brooks B.W. Bioaccumulation and trophic dilution of human pharmaceuticals across trophic positions of an effluent-dependent wadeable stream. Philos. Trans. R. Soc. B 2014, 369.
23. FDA FDA Professional Drug Information (Accessed July 2014). http://www.drugs.com/pro.
24. Fernandez M., Fernandez M., Laca A., Laca A., Diaz M. Seasonal occurrence and removal of pharmaceutical products in municipal wastewaters. J. Environ. Chem. Eng. 2014, 2:495-502.
25. Forest E. Atypical Drugs of Abuse 2008, Student Doctor Network, (http://www.studentdoctor.net/2008/07/atypical-drugs-of-abuse/ Accessed May 2014).
26. Franzellitti S., Buratti S., Valbonesi P., Capuzzo A., Fabbri E. The β-blocker propranolol affects cAMP-dependent signalling and induces the stress response in Mediterranean mussels, Mytilus galloprovincialis. Aquat. Toxicol. 2011, 101:299-308.
27. Gabet-Giraud V., Miege C., Choubert J.M., Ruel S.M., Coquery M. Occurrence and removal of estrogens and beta blockers by various processes in wastewater treatment plants. Sci. Total Environ. 2010, 408:4257-4269.
28. Gabet-Giraud V., Miege C., Jacquet R., Coquery M. Impact of wastewater treatment plants on receiving surface waters and a tentative risk evaluation: the case of estrogens and beta blockers. Environ. Sci. Pollut. Res. 2014, 21:1708-1722.
29. Galus M., Kirischian N., Higgins S., Purdy J., Chow J., Rangaranjan S., Li H., Metcalfe C., Wilson J.Y. Chronic, low concentration exposure to pharmaceuticals impacts multiple organ systems in zebrafish. Aquat. Toxicol. 2013, 132-133:200-211.
30. Gao P., Ding Y., Li H., Xagoraraki I. Occurrence of pharmaceuticals in a municipal wastewater treatment plant: mass balance and removal processes. Chemosphere 2012, 88(1):17-24.
31. Gomes R.L., Scrimshaw M.D., Lester J.N. Fate of conjugated natural and synthetic steroid estrogens in crude sewage and activated sludge batch studies. Environ. Sci. Technol. 2009, 43:3612-3618.
32. Goolsby E.W., Mason C.M., Wojcik J.T., Jordan A.M., Black M.C. Acute and chronic effects of diphenhydramine and sertraline mixtures in Ceriodaphnia dubia. Environ. Toxicol. Chem. 2013, 32(12):2866-2869.
33. Gracia-Lor E., Sancho J.V., Serrano R., Hernández F. Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia. Chemosphere 2012, 87:453-462.
34. Gros M., Petrovic M., Ginebreda A., Barcelo D. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ. Int. 2010, 36:15-26.
35. Gunnarsson L., Jauhiainen A., Kristiansson E., Nerman O., Larsson D.G.J. Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ. Sci. Technol. 2008, 42:5807-5813.
36. Halpert A.G., Olmstead M.C., Beninger R.J. Mechanisms and abuse liability of the anti-histamine dimenhydrinate. Neurosci. Biobehav. Rev. 2002, 26:61-67.
37. Heidler J., Halden R.U. Mass balance assessment of triclosan removal during conventional sewage treatment. Chemosphere 2007, 66:362-369.
38. Higgins C.P., Paesani Z.J., Abbott Chalew T.E., Halden R.U., Hundal L.S. Persistence of triclocarban and triclosan in soils after land application of biosolids and bioaccumulation in Eisenia foetida. Environ. Toxicol. Chem. 2011, 30(3):556-563.
39. Ings J.S., George N., Peter M.C.S., Servos M.R., Vijayan M.M. Venlafaxine and atenolol disrupt epinephrine-stimulated glucose production in rainbow trout hepatocytes. Aquat. Toxicol. 2012, 106-107:48-55.
40. Jelic A., Gros M., Ginebreda A., Cespedes-Sànchez R., Ventura F., Petrovic M., Barcelo D. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res. 2011, 45:1165-1176.
41. Kinney C.A., Furlong E.T., Werner S.L., Cahill J.D. Presence and distribution of wastewater-derived pharmaceuticals in soil irrigated with reclaimed water. Environ. Toxicol. Chem. 2006, 25(2):317-326.
42. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36:1202-1211.
43. Kosjek T., Andersen H.R., Kompare B., Ledin A., Heath E. Fate of carbamazepine during water treatment. Environ. Sci. Technol. 2009, 43:6256-6261.
44. Kwon J.W., Rodriguez J.M. Occurrence and removal of selected pharmaceuticals and personal care products in three wastewater treatment plants. Arch. Environ. Contam. Toxicol. 2014, 66:538-548.
45. Lajeunesse A., Smyth S.A., Barclay K., Sauvé S., Gagnon C. Distribution of antidepressant residues in wastewater and biosolids following different treatment processes by municipal wastewater treatment plants in Canada. Water Res. 2012, 46:5600-5612.
46. Langdon K.A., Warne M.St.J., Smernik R.J., Shareef A., Kookana R.S. Degradation of 4-nonylphenol, 4-t-octylphenol, bisphenol-A and triclosan following biosolids addition to soil under laboratory conditions. Chemosphere 2011, 84:1556-1562.
47. Liu J.L., Wong M.H. Pharmaceuticals and personal care products (PPCPs): a review on environmental contamination in China. Environ. Int. 2013, 59:208-224.
48. Lorenzi V., Mehinto A.C., Denslow N.D., Schlenk D. Effects of exposure to the β-blocker propranolol on the reproductive behaviour and gene expression of the fathead minnow, Pimephales promelas. Aquat. Toxicol. 2012, 116-117:8-15.
49. Massarsky A., Trudeau V.L., Moon T.W. Β-blockers as endocrine disruptors: the potential effects of human β-blockers on aquatic organisms. J. Exp. Zool. 2011, 315:251-265.
50. MDBA About the Basin 2014, Australian Government Murray Darling Basin Authority, (http://www.mdba.gov.au/about-basin. 2014 Murray Darling Basin Authority. Accessed November 2014).
51. MDBA Murrumbidgee 2014, Australian Government Murray Darling Basin Authority, (http://www.mdba.gov.au/about-basin/how-river-runs/murrumbidgee-catchment. 2014 Murray Darling Basin Authority. Accessed November 2014).
52. Menningen J.A., Sassine J., Trudeau V.L., Moon T.W. Waterborne fluoxetine disrupts feeding and energy metabolism in the goldfish Carassius auratus. Aquat. Toxicol. 2010, 100:128-137.
53. Menningen J.A., Lado W.E., Zamora J.M., Duarte-Guterman P., Langlois V.S., Metcalfe C.D., Chang J.P., Moon T.W., Trudeau V.L. Waterborne fluoxetine disrupts the reproductive axis in sexually mature male goldfish, Carassius auratus. Aquat. Toxicol. 2010, 100:354-364.
54. Metcalfe C.D., Chu S., Judt C., Li H., Oakes K.D., Servos M.R., Andrews D.M. Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed. Environ. Toxicol. Chem. 2010, 29(1):79-89.
55. Miao X., Yang J., Metcalfe C.D. Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant. Environ. Sci. Technol. 2005, 39:7469-7475.
56. Minagh E., Hernan R., O'Rourke K., Lyng F.M., Davoren M. Aquatic ecotoxicity of the selective serotonin reuptake inhibitor sertraline hydrochloride in a battery of freshwater test species. Ecotoxicol. Environ. Saf. 2009, 72:434-440.
57. Montagner C.C., Jardim W.F., Von der Ohe P.C., Umbuzeiro G.A. Occurrence and potential risk of triclosan in freshwaters of Sao Paulo, Brazil - the need for regulatory actions. Environ. Sci. Pollut. Res. 2014, 21:1850-1858.
58. NICNAS Triclosan Fact Sheet 2013, National Industrial Chemicals Notification and Assessment Scheme, Australian Government Department of Health, (http://www.nicnas.gov.au/communications/publications/information-sheets/existing-chemical-info-sheets/triclosan-factsheet Accessed July 2014).
59. Orvos D.R., Versteeg D.J., Inauen J., Capdevielle M., Rothenstein A., Cunningham V. Aquatic toxicity of triclosan. Environ. Toxicol. Chem. 2002, 21(7):1338-1349.
60. Owen S.F., Giltrow E., Huggett D.B., Hutchinson T.H., Saye J., Winter M.J., Sumpter J.P. Comparative physiology, pharmacology and toxicology of β-blockers: mammals versus fish. Aquat. Toxicol. 2007, 82:145-162.
61. Painter M.M., Buerkley M.A., Julius M.L., Vajda A.M., Norris D.O., Barber L.B., Furlong E.T., Schultz M.M., Schoenfuss H.L. Antidepressants at environmentally relevant concentrations affect predator avoidance behaviour of larval fathead minnows (Pimephales promelas). Environ. Toxicol. Chem. 2009, 28(12):2677-2684.
62. Pharmgkb Pharmacogenomics Knowledge Base (Accessed 2014). http://www.pharmgkb.org.
63. Roberts K., Gruer L., Gilhooly T. Misuse of diphenhydramine soft gel capsules (Sleepia®): a cautionary tale from Glasgow. Addiction 1999, 94(10):1575-1578.
64. Rua-Gomez P.C., Puttmann W. Impact of wastewater treatment plant discharge of lidocaine, tramadol, venlafaxine and their metabolites on the quality of surface waters and groundwater. J. Environ. Monit. 2012, 14:1391-1399.
65. Santos L.H.M.L.M., Gros M., Rodriguez-Mozaz S., Delerue-Matos C., Pena A., Barceló D., Montenegro M.C.B.S.M. Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals. Sci. Total Environ. 2013, 461-462:302-316.
66. Schultz M.M., Furlong E.T., Kolpin D.W., Werner S.L., Schoenfuss H.L., Barber L.B., Blazer V.S., Norris D.O., Vajda A.M. Antidepressant pharmaceuticals in two U.S. effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue. Environ. Sci. Technol. 2010, 44:1918-1925.
67. Singer H., Muller S., Tixier C., Pillonel L. Triclosan: occurrence and fate of a widely used biocide in the aquatic environment: field measurements in wastewater treatment plants, surface waters, and lake sediments. Environ. Sci. Technol. 2002, 36:4998-5004.
68. Snyder S.A., Westerhoff P., Yoon Y., Sedlak D.L. Pharmaceuticals, personal care products, and endocrine disruptors in water: implications for the water industry. Environ. Eng. Sci. 2003, 20(5):449-469.
69. Snyder S.A., Vanderford B.J., Drewes J., Dickenson E., Snyder E.M., Bruce G.M., Pleus R.C. State of Knowledge of Endocrine Disruptors and Pharmaceuticals in Drinking Water 2008, AWWA Research Foundation.
70. Spongberg A.L., Witter J.D. Pharmaceutical compounds in the wastewater process stream in Northwest Ohio. Sci. Total Environ. 2008, 397:148-157.
71. State of the Climate Australian Bureau of Meteorology and the Commonwealth Scientific and Industrial Research Organisation (CSIRO) 2014, ( Commonwealth of Australia 2014).
72. Suarez S., Carballa M., Omil F., Lema J.M. How are pharmaceuticals and personal care products (PPCPs) removed from urban wastewaters?. Rev. Environ. Sci. Biotechnol. 2008, 7:125-138.
73. Subedi B., Du B., Chambiss C.K., Koschorreck J., Rudel H., Quack M., Brooks B.W., Usenko S. Occurrence of pharmaceuticals and personal care products in German fish tissue: a national study. Environ. Sci. Technol. 2012, 46:9047-9054.
74. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32(11):3245-3260.
75. Thomas A., Nallur D.G., Jones N., Deslandes P.N. Diphenhydramine abuse and detoxification: a brief review and case report. J. Psychopharmacol. 2009, 23(1):101-105.
76. Thomas M.A., Joshi P.P., Klaper R.D. Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems. Comp. Biochem. Physiol. C 2012, 155:109-120.
77. Topp E., Sumarah M.W., Sabourin L. The antihistamine diphenhydramine is extremely persistent in agricultural soil. Sci. Total Environ. 2012, 439:136-140.
78. Valcárel Y., Gonzáles Alonso S., Rodríguez-Gil J.L., Gil A., Catalá M. Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid Region (Spain) ad potential ecotoxicological risk. Chemosphere 2011, 84:1336-1348.
79. Valdes M.E., Ame M.V., Bistoni M.A., Wunderlin D.A. Occurrence and bioaccumulation of pharmaceuticals in a fish species inhabiting the Suquia River basin (Cordoba, Argentina). Sci. Total Environ. 2014, 472:389-396.
80. Vasskog T., Berger U., Samuelsen P.J., Kallenborn R., Jensen E. Selective serotonin reuptake inhibitors in sewage effluents and effluents from Tromso. Norway. J. Chromatogr. A. 2006, 1115:187-195.
81. Vieno N., Tuhkanen T., Kronberg L. Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Res. 2007, 41:1001-1012.
82. Walters E., McClellan K., Halden R.U. Occurrence and loss over three years of 72 pharmaceuticals and personal care products from biosolids-soil mixtures in outdoor mesocosms. Water Res. 2010, 44:6011-6020.
83. Wang J., Gardinali P.R. Uptake and depuration of pharmaceuticals in reclaimed water by mosquito fish (Gambusia holbrooki): a worst-case, multiple-exposure scenario. Environ. Toxicol. Chem. 2013, 32(8):1752-1758.
84. WERF Water Environment Research Foundation. Fate of pharmaceuticals and personal care products in wastewater treatment 2007, Project number: 03-CTS-22UR. Principal investigator: Roger Stephenson.
85. Wick A., Fink G., Joss A., Siegrist H., Ternes T.A. Fate of beta blockers and psycho-active drugs in conventional wastewater treatment. Water Res. 2009, 43:1060-1074.
86. Williams M., Kumar A., Ort C., Lawrence M., Hambly A., Khan S., Kookana R. The use of multiple tracers for tracking wastewater discharges in freshwater systems. Environ. Monit. Assess. 2013, 185(11):9321-9332.
87. Writer J.H., Keefe S.K., Ryan J.N., Ferrer I., Thurman M.E., Barber L.B. Methods for evaluating in-stream attenuation of trace organic compounds. Appl. Geochem. 2011, 26:5344-5345.
88. Writer J.H., Ferrer I., Barber L.B., Thruman E.M. Widespread occurrence of neuro-active pharmaceuticals and metabolites in 24 Minnesota rivers and wastewaters. Sci. Total Environ. 2013, 461-462:519-527.
89. Ying G.G., Kookana R.S. Triclosan in wastewaters and biosolids from Australian wastewater treatment plants. Environ. Int. 2007, 33(2):199-205.
90. Yu Y., Wu L., Chang A.C. Seasonal variation of endocrine disrupting compounds, pharmaceuticals and personal care products in wastewater treatment plants. Sci. Total Environ. 2013, 442:310-316.